Antibiotic prophylaxis for hip fracture surgical procedure: three-dose cefuroxime versus single-dose gentamicin and amoxicillin.
OBJECTIVE
To check a 3-dose cefuroxime routine with a single-dose gentamicin and amoxicillin routine as antibiotic prophylaxis for hip hemiarthroplasty when it comes to microbiological consequence.
METHODS
Information of two matched teams of sufferers who underwent hip hemiarthroplasty for femoral neck fractures had been reviewed. 29 males and 84 girls (imply age, 82 years) who acquired a 3-dose cefuroxime routine in 2006 had been in contrast with 23 males and 84 girls (imply age, 83 years) who acquired a single-dose gentamicin and amoxicillin routine in 2008.
Affected person demographics, antibiotics prescribed within the peri- and speedy postoperative interval, microbiological proof for Clostridium difficile ‘an infection’, size of hospital keep, mortality, in addition to biochemical and haematological findings had been reviewed.
RESULTS
The three-dose cefuroxime group was considerably larger when it comes to the imply size of hospital keep (17 vs. 13 days, p=0.043) and the proportion of sufferers receiving postoperative antibiotics (88% vs. 68%, p<0.001) and having C difficile ‘an infection’ (6% vs. 0%, p=0.016). If sufferers with C difficile ‘an infection’ had been excluded, there was no important distinction within the size of hospital keep.
CONCLUSIONS
The only-dose gentamicin and amoxicillin routine was related to a decrease C difficile ‘an infection’ charge
Profitable prevention of tunneled central catheter an infection by antibiotic lock remedy utilizing cefazolin and gentamicin.
Catheter-related bacteremia (CRB) is among the numerous issues associated to hemodialysis (HD). On account of this excessive charge of an infection, the antibiotic lock approach (ALT) has been advisable to stop CRB. Nevertheless, hostile results of ALT equivalent to elevated emergence of strains proof against antibiotics and elevated mechanical dysfunction catheter had been poorly evaluated.
We prospectively evaluated the efficacy of catheter-restricted filling utilizing an antibiotic lock answer in stopping CRB. A complete of 233 HD sufferers requiring 325 new tunneled catheters whereas ready for placement and maturation of an arteriovenous fistula or graft had been enrolled on this research.
Sufferers with a tunneled catheter had been assigned to obtain both an antibiotic-heparin lock answer (antibiotic group: cefazolin 10 mg/ml, gentamicin 5 mg/ml, heparin 1,000 U/ml) or a heparin lock answer (no-antibiotic group: heparin 1,000 U/ml) as a catheter lock answer through the interdialytic interval.
The current research aimed to evaluate the efficacy of ALT utilizing cefazolin and gentamicin in lowering CRB in sufferers present process HD with tunneled central catheter and to establish its hostile results. CRB developed in 32.4 % of sufferers within the no-antibiotic group and in 13.1 % of sufferers within the antibiotic group.
- CRB charges per 1,000 catheter-days had been 0.57 within the antibiotic group versus 1.74 within the no-antibiotic group (p < 0.0001). Kaplan-Meier evaluation additionally confirmed that imply CRB-free catheter survival was considerably larger within the antibiotic group than within the no-antibiotic group (log-rank statistic 17.62, p < 0.0001).
- There was statistically important distinction between the two teams in causative organisms of CRB, with predominance of detrimental tradition in each teams, however this prevalence was larger in ALT group (57.9 vs 90.1 %, p < 0.0001), and the 2 teams additionally had been completely different in prevalence of gram-positive micro organism as inflicting organisms (ALT group 21.05 vs = 0 % in management group, p < 0.0001).
- There was no statistically important distinction between the 2 teams in drug-resistant germs. There have been statistically important variations between the 2 teams within the catheter removing causes, with larger charge of infectious trigger in management group (12.32 vs 2.22 %, p < 0.0001) and mechanical trigger in ALT group (28.26 vs 37.78 %, p < 0.0001).
- The outcomes recommend that ALT could also be a helpful technique of lowering the CRB charge in HD sufferers with tunneled catheter, with out affiliation between ALT and emergence of strains resistant. Nevertheless, mechanical issues had been extra prevalent in antibiotic group. Additional research are required to find out the optimum drug routine, concentrations for ALT, and its hostile results.
Gentamicin C1 pentaacetate salt |
|||
| GA1270-10MG | Glentham Life Sciences | 10 mg | EUR 783.6 |
Gentamicin C1 pentaacetate salt |
|||
| GA1270-1MG | Glentham Life Sciences | 1 mg | EUR 204 |
Gentamicin C1 Pentaacetate Salt |
|||
| MBS651207-1mg | MyBiosource | 1mg | EUR 620 |
Gentamicin C1 Pentaacetate Salt |
|||
| MBS651207-5x1mg | MyBiosource | 5x1mg | EUR 2635 |
Gentamicin C2 Pentaacetate Salt (Mixture of C2 and C2a) |
|||
| G360595 | Toronto Research Chemicals | 10mg | EUR 293 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559 | Glentham Life Sciences | 10mg | EUR 702.4 |
Gentamicin C1a Pentaacetate Salt |
|||
| G360590 | Toronto Research Chemicals | 10mg | EUR 655 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559-10 | Glentham Life Sciences | 10 | EUR 395.5 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559-10MG | Glentham Life Sciences | 10 mg | EUR 514.8 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559-25 | Glentham Life Sciences | 25 | EUR 767.1 |
Gentamicin C1a pentaacetate salt |
|||
| GA4559-25MG | Glentham Life Sciences | 25 mg | EUR 964.8 |
Gentamicin C1a Pentaacetate Salt |
|||
| MBS651561-1mg | MyBiosource | 1mg | EUR 545 |
Gentamicin C1a Pentaacetate Salt |
|||
| MBS651561-5x1mg | MyBiosource | 5x1mg | EUR 2310 |
Gentamicin C1A Deuterated Pentaacetate Salt |
|||
| G360592 | Toronto Research Chemicals | 0.5mg | EUR 2182 |
Gentamicin C1 Deuterated Pentaacetate Salt (>90%) |
|||
| G360587 | Toronto Research Chemicals | 0.5mg | EUR 2681 |
|
Description: 287730-69-2 |
|||
Gentamicin C2/C2a Deuterated Mixture Pentaacetate Salt (d2 major) |
|||
| G360597 | Toronto Research Chemicals | 0.5mg | EUR 1935 |
Gentamicin Deuterated (C Complex) Pentaacetate Salt(Contains d0) |
|||
| G360602 | Toronto Research Chemicals | 10mg | EUR 253 |
Gentamicin Deuterated (C Complex) Pentaacetate Salt (contains d0) |
|||
| MBS6116927-1mg | MyBiosource | 1(mg | EUR 590 |
Gentamicin Deuterated (C Complex) Pentaacetate Salt (contains d0) |
|||
| MBS6116927-5x1mg | MyBiosource | 5x1mg | EUR 2500 |
Catechin pentaacetate |
|||
| TB00383 | ChemNorm | 5mg | EUR 886.8 |
Syringin pentaacetate |
|||
| TN5087-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Syringin pentaacetate |
|||
Syringin pentaacetate |
|||
| TN5087-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Syringin pentaacetate |
|||
Syringin pentaacetate |
|||
| TN5087-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Syringin pentaacetate |
|||
Syringin pentaacetate |
|||
| TN5087-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Syringin pentaacetate |
|||
Syringin pentaacetate |
|||
| TN5087-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Syringin pentaacetate |
|||
Bergenin pentaacetate |
|||
| TN3498-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Bergenin pentaacetate |
|||
Bergenin pentaacetate |
|||
| TN3498-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Bergenin pentaacetate |
|||
Bergenin pentaacetate |
|||
| TN3498-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Bergenin pentaacetate |
|||
Bergenin pentaacetate |
|||
| TN3498-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Bergenin pentaacetate |
|||
Bergenin pentaacetate |
|||
| TN3498-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Bergenin pentaacetate |
|||
Catechin pentaacetate |
|||
| TN3610-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Catechin pentaacetate |
|||
Catechin pentaacetate |
|||
| TN3610-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Catechin pentaacetate |
|||
Catechin pentaacetate |
|||
| TN3610-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Catechin pentaacetate |
|||
Catechin pentaacetate |
|||
| TN3610-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Catechin pentaacetate |
|||
Catechin pentaacetate |
|||
| TN3610-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Catechin pentaacetate |
|||
Bergenin pentaacetate |
|||
| MBS5761950-1mg | MyBiosource | 1mg | EUR 260 |
Bergenin pentaacetate |
|||
| MBS5761950-5x1mg | MyBiosource | 5x1mg | EUR 1025 |
Catechin pentaacetate |
|||
| MBS5762041-1mg | MyBiosource | 1mg | EUR 235 |
Catechin pentaacetate |
|||
| MBS5762041-5x1mg | MyBiosource | 5x1mg | EUR 905 |
Syringin pentaacetate |
|||
| MBS5763170-1mg | MyBiosource | 1mg | EUR 260 |
Syringin pentaacetate |
|||
| MBS5763170-5x1mg | MyBiosource | 5x1mg | EUR 1025 |
Quercetin pentaacetate |
|||
| T38343-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Quercetin pentaacetate |
|||
Quercetin pentaacetate |
|||
| T38343-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Quercetin pentaacetate |
|||
Quercetin pentaacetate |
|||
| T38343-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Quercetin pentaacetate |
|||
Quercetin pentaacetate |
|||
| T38343-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Quercetin pentaacetate |
|||
Quercetin pentaacetate |
|||
| T38343-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Quercetin pentaacetate |
|||
Quercetin pentaacetate |
|||
| MBS5785372-10mg | MyBiosource | 10(mg | EUR 275 |
Quercetin pentaacetate |
|||
| MBS5785372-2mg | MyBiosource | 2(mg | EUR 190 |
Quercetin pentaacetate |
|||
| MBS5785372-5mg | MyBiosource | 5(mg | EUR 225 |
Quercetin pentaacetate |
|||
| HY-124512 | MedChemExpress | 10 mg | EUR 122.3 |
|
Description: Quercetin pentaacetate could interact with F-protein with lower binding energy and better stability to block viral adhesion. Quercetin pentaacetate interacts with RSV and inhibit the viral adhesion on cell surface[1][2]. |
|||
4,6-O-Benzylidene Lactosamine 6-Sulfate Pentaacetate Triethylamine Salt |
|||
| MBS6085581-5mg | MyBiosource | 5(mg | EUR 545 |
4,6-O-Benzylidene Lactosamine 6-Sulfate Pentaacetate Triethylamine Salt |
|||
| MBS6085581-5x5mg | MyBiosource | 5x5(mg | EUR 2310 |
Epicatechin pentaacetate |
|||
| TBW00666 | ChemNorm | unit | Ask for price |
Epicatechin pentaacetate |
|||
| TN3966-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Epicatechin pentaacetate |
|||
Epicatechin pentaacetate |
|||
| TN3966-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Epicatechin pentaacetate |
|||
Epicatechin pentaacetate |
|||
| TN3966-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Epicatechin pentaacetate |
|||
Epicatechin pentaacetate |
|||
| TN3966-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Epicatechin pentaacetate |
|||
Epicatechin pentaacetate |
|||
| TN3966-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Epicatechin pentaacetate |
|||
Epicatechin pentaacetate |
|||
| MBS5787113-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Gentamicin sulfate salt |
|||
| 20-abx082235 | Abbexa |
|
|
Gentamicin sulfate salt |
|||
| abx082235-100l | Abbexa | 100 µl | EUR 162.5 |
Gentamicin sulfate salt |
|||
| abx082235-1ml | Abbexa | 1 ml | Ask for price |
Gentamicin sulfate salt |
|||
| abx082235-200l | Abbexa | 200 µl | EUR 212.5 |
D-Galactose Pentaacetate |
|||
| G155700 | Toronto Research Chemicals | 100g | EUR 64 |
D-Galactose Pentaacetate |
|||
| MBS6098128-5g | MyBiosource | 5(g | EUR 410 |
D-Galactose Pentaacetate |
|||
| MBS6098128-5x5g | MyBiosource | 5x5g | EUR 1700 |
Sucralose-d6 Pentaacetate |
|||
| S692507 | Toronto Research Chemicals | 100mg | EUR 11200 |
6-Thiofucose Pentaacetate |
|||
| T112255 | Toronto Research Chemicals | 10mg | EUR 3000 |
|
Description: 1456696-03-9 |
|||
Mulberrofuran G pentaacetate |
|||
| TN5671-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Mulberrofuran G pentaacetate |
|||
Mulberrofuran G pentaacetate |
|||
| TN5671-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Mulberrofuran G pentaacetate |
|||
Mulberrofuran G pentaacetate |
|||
| TN5671-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Mulberrofuran G pentaacetate |
|||
Mulberrofuran G pentaacetate |
|||
| TN5671-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Mulberrofuran G pentaacetate |
|||
Mulberrofuran G pentaacetate |
|||
| TN5671-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Mulberrofuran G pentaacetate |
|||
Mulberrofuran G pentaacetate |
|||
| MBS5787776-5mg | MyBiosource | 5(mg | EUR 490 |
Mulberrofuran G pentaacetate |
|||
| MBS5787776-5x5mg | MyBiosource | 5x5(mg | EUR 2050 |
D-Glucose 2,3,4,5,6-Pentaacetate |
|||
| abx188676-1kg | Abbexa | 1 kg | EUR 477.6 |
a-D-Glucose pentaacetate |
|||
| RM4288-25G | EWC Diagnostics | 1 unit | EUR 34.17 |
|
Description: a-D-Glucose pentaacetate |
|||
a-D-Mannose pentaacetate |
|||
| GC3160 | Glentham Life Sciences | 5g | EUR 215.12 |
a-D-Glucose Pentaacetate |
|||
| G596495 | Toronto Research Chemicals | 50g | EUR 138 |
|
Description: 604-68-2 |
|||
a-D-Mannose pentaacetate |
|||
| GC3160-10 | Glentham Life Sciences | 10 | EUR 234.9 |
a-D-Mannose pentaacetate |
|||
| GC3160-5 | Glentham Life Sciences | 5 | EUR 134.4 |
β-D-Glucose pentaacetate |
|||
| T7997-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: β-D-Glucose pentaacetate |
|||
β-D-Glucose pentaacetate |
|||
| T7997-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: β-D-Glucose pentaacetate |
|||
β-D-Glucose pentaacetate |
|||
| T7997-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: β-D-Glucose pentaacetate |
|||
β-D-Glucose pentaacetate |
|||
| T7997-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: β-D-Glucose pentaacetate |
|||
β-D-Glucose pentaacetate |
|||
| T7997-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: β-D-Glucose pentaacetate |
|||
b-D-Glucose Pentaacetate |
|||
| MBS6100396-50g | MyBiosource | 50(g | EUR 410 |
b-D-Glucose Pentaacetate |
|||
| MBS6100396-5x50g | MyBiosource | 5x50g | EUR 1700 |
β-D-Glucose pentaacetate |
|||
| HY-22306 | MedChemExpress | 10 g | EUR 27.06 |
|
Description: β-D-Glucose Pentaacetate (Penta-O-acetyl-β-D-glucopyranose) is used in biochemical reaction. |
|||
β-D-Glucose pentaacetate-13C6 |
|||
| HY-22306S | MedChemExpress | Get quote | Ask for price |
|
Description: β-D-Glucose pentaacetate-13C6 is the 13C labeled β-D-Glucose pentaacetate[1]. β-D-Glucose Pentaacetate (Penta-O-acetyl-β-D-glucopyranose) is used in biochemical reaction. |
|||
D-Galactofuranose Pentaacetate |
|||
| MBS6031927-100mg | MyBiosource | 100(mg | EUR 610 |
Impact of storage temperature on gentamicin launch from antibiotic-coated bone chips.
Freezing is the most typical technique for storing bones till use in skeletal reconstruction. Nevertheless, the impact of freezing on antibiotic supply from antibiotic-coated bone has not been evaluated. On this research, we in contrast antibiotic supply in vitro from gentamicin-coated human bone saved at completely different temperatures.
Bone chips obtained from human femur heads had been chemically cleaned and blended with gentamicin sulfate. Samples had been saved for Four months at -20 °C, Four months at -80 °C, or evaluated instantly with out freezing. Antibiotic launch from the bone chips was measured utilizing Bacillus subtilis as an indicator pressure.
Zones of inhibition and charges of gentamicin launch had been related in all three teams. Storage at -20 and -80 °C for bone allografts has no impact on gentamicin launch from chemically cleaned bone chips.
Gentamicin sulfate |
|||
| B1270-1G | Biovision | each | EUR 170.4 |
Gentamicin sulfate |
|||
| B1270-25G | Biovision | each | EUR 1136.4 |
Gentamicin sulfate |
|||
| B1270-5G | Biovision | each | EUR 405.6 |
Gentamicin sulfate |
|||
| GA7939 | Glentham Life Sciences | 1g | EUR 115.8 |
GENTAMICIN SULFATE |
|||
| G570 | PhytoTechnology Laboratories | 10G | EUR 32.75 |
Gentamicin (sulfate) |
|||
| HY-A0276 | MedChemExpress | 500mg | EUR 142.8 |
Gentamicin sulfate |
|||
| GA7939-1 | Glentham Life Sciences | 1 | EUR 15.9 |
Gentamicin sulfate |
|||
| GA7939-10 | Glentham Life Sciences | 10 | EUR 71.1 |
Gentamicin sulfate |
|||
| GA7939-10G | Glentham Life Sciences | 10 g | EUR 122.4 |
Gentamicin sulfate |
|||
| GA7939-1G | Glentham Life Sciences | 1 g | EUR 55.2 |
Gentamicin sulfate |
|||
| GA7939-25 | Glentham Life Sciences | 25 | EUR 126.5 |
Gentamicin sulfate |
|||
| GA7939-25G | Glentham Life Sciences | 25 g | EUR 189.6 |
Gentamicin sulfate |
|||
| GA7939-5 | Glentham Life Sciences | 5 | EUR 47.4 |
Gentamicin sulfate |
|||
| GA7939-5G | Glentham Life Sciences | 5 g | EUR 93.6 |
Gentamicin sulfate |
|||
| T1326-10mg | TargetMol Chemicals | 10mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-1g | TargetMol Chemicals | 1g | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-1mg | TargetMol Chemicals | 1mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-50mg | TargetMol Chemicals | 50mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin sulfate |
|||
| T1326-5mg | TargetMol Chemicals | 5mg | Ask for price |
|
Description: Gentamicin sulfate |
|||
Gentamicin X2 Sulfate |
|||
| 565235 | MedKoo Biosciences | 1.0mg | EUR 380 |
Gentamicin Sulfate EP |
|||
| G007-25G | TOKU-E | 25 g | EUR 309.86 |
|
Description: C21H43N5O7 • H2SO4 |
|||
Gentamicin Sulfate EP |
|||
| G007-5G | TOKU-E | 5 g | EUR 128.8 |
|
Description: C21H43N5O7 • H2SO4 |
|||
Gentamicin X2 Sulfate |
|||
| G360605 | Toronto Research Chemicals | 0.5mg | EUR 2223 |
|
Description: 57793-88-1 |
|||
Gentamicin B Sulfate |
|||
| G360650 | Toronto Research Chemicals | 25mg | EUR 25000 |
|
Description: 43169-50-2 |
|||
Gentamicin Sulfate - 1g |
|||
| PM-A4120/1 | Biosera France - Medical Scientific Equipment | 1g | EUR 5.89 |
Gentamicin Sulfate - 5g |
|||
| PM-A4120/5 | Biosera France - Medical Scientific Equipment | 5g | EUR 18.7 |
Gentamicin Sulfate USP |
|||
| G006-25G | TOKU-E | 25 g | EUR 215.79 |
|
Description: N/A |
|||
Gentamicin Sulfate USP |
|||
| G006-5G | TOKU-E | 5 g | EUR 64.06 |
|
Description: N/A |
|||
Gentamicin sulfate salt |
|||
| 20-abx082235 | Abbexa |
|
|
Gentamicin sulfate salt |
|||
| abx082235-100l | Abbexa | 100 µl | EUR 162.5 |
Gentamicin sulfate salt |
|||
| abx082235-1ml | Abbexa | 1 ml | Ask for price |
Gentamicin sulfate salt |
|||
| abx082235-200l | Abbexa | 200 µl | EUR 212.5 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-100g | MyBiosource | 100g | EUR 570 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-1kg | MyBiosource | 1kg | EUR 1495 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-25g | MyBiosource | 25g | EUR 440 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-500g | MyBiosource | 500g | EUR 860 |
Gentamycin (Gentamicin) Sulfate USP |
|||
| MBS651447-5g | MyBiosource | 5g | EUR 210 |
0.1g Gentamicin Sulfate Powder |
|||
| 61-098-RA | Scientific Laboratory Supplies | EACH | EUR 58.37 |
1g Gentamicin Sulfate Powder |
|||
| 61-098-RF | Scientific Laboratory Supplies | EACH | EUR 76.38 |
Gentamicin Sulfate, Animal-Free |
|||
| 19771-01 | NACALAI TESQUE | 1G | EUR 53.2 |
Gentamicin Sulfate, Animal-Free |
|||
| 19771-14 | NACALAI TESQUE | 5G | EUR 168 |
Gentamicin Sulfate, Animal-Free |
|||
| 19771-72 | NACALAI TESQUE | 25G | EUR 630 |
Gentamicin Sulfate 10 mg/ml - 100ml |
|||
| LM-A4111/100 | Biosera France - Medical Scientific Equipment | 100ml | EUR 20.19 |
Gentamicin Sulfate 50 mg/ml - 100ml |
|||
| LM-A4112/100 | Biosera France - Medical Scientific Equipment | 100ml | EUR 30.25 |
Gentamicin C1 Sulfate EvoPure® |
|||
| G031-10MG | TOKU-E | 10 mg | EUR 569.63 |
|
Description: C21H43N5O7• xH2SO4 (lot specific) |
|||
Gentamicin C2 sulfate EvoPure® |
|||
| G033-10MG | TOKU-E | 10 mg | EUR 569.63 |
|
Description: C20H41N5O7• xH2SO4(lot specific) |
|||
Gentamicin A sulfate EvoPure® |
|||
| G035-10MG | TOKU-E | 10 mg | EUR 311.7 |
|
Description: C18H36N4O10• xH2SO4 (lot specific) |
|||
Gentamicin X2 sulfate EvoPure® |
|||
| G036-2.5MG | TOKU-E | 2.5 mg | EUR 36 |
|
Description: C19H38N4O10• xH2SO4 (lot specific) |
|||
Gentamicin X2 sulfate EvoPure® |
|||
| G036-PleaseContactusforPricing | TOKU-E | Please Contact us for Pricing | EUR 36 |
|
Description: C19H38N4O10• xH2SO4 (lot specific) |
|||
Gentamicin C1a sulfate EvoPure® |
|||
| G032-10MG | TOKU-E | 10 mg | EUR 569.63 |
|
Description: C19H39N5O7• xH2SO4 (lot specific) |
|||
Gentamicin C2a sulfate EvoPure® |
|||
| G034-10MG | TOKU-E | 10 mg | EUR 569.63 |
|
Description: C20H41N5O7• xH2SO4 (lot specific) |
|||
Gentamicin Sulfate 10 mg/ml - 10ml |
|||
| LM-A4111/10 | Biosera France - Medical Scientific Equipment | 10ml | EUR 5.5 |
Gentamicin Sulfate 50 mg/ml - 10ml |
|||
| LM-A4112/10 | Biosera France - Medical Scientific Equipment | 10ml | EUR 6.11 |
Gentamicin Sulfate Salt (C Complex) |
|||
| G360600 | Toronto Research Chemicals | 1g | EUR 63 |
|
Description: 1405-41-0 |
|||
Gentamicin Sulfate Solution(10mg/ml) |
|||
| 16672-04 | NACALAI TESQUE | 10ML | EUR 16.1 |
Gentamicin Sulfate Solution(50mg/ml) |
|||
| 11980-14 | NACALAI TESQUE | 10ML | EUR 56 |
10mL Gentamicin Sulfate Liquid 5 - PK10 |
|||
| 30-005-CR | Scientific Laboratory Supplies | PK10 | EUR 650.7 |
Gentamicin sulfate/Amphotericin (GA-1000) |
|||
| LOCC-4083 | Westburg | each | Ask for price |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-10x20mL | MyBiosource | 10x20mL | EUR 970 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-20mL | MyBiosource | 20mL | EUR 220 |
Gentamycin (Gentamicin) Sulfate Solution 50mg/ml |
|||
| MBS651312-5x20mL | MyBiosource | 5x20mL | EUR 610 |
Gentamycin (Gentamicin) Sulfate Solution 10mg/ml |
|||
| MBS651400-10x20mL | MyBiosource | 10x20mL | EUR 315 |
Gentamycin (Gentamicin) Sulfate Solution 10mg/ml |
|||
| MBS651400-20mL | MyBiosource | 20mL | EUR 160 |
Gentamycin (Gentamicin) Sulfate Solution 10mg/ml |
|||
| MBS651400-5x20mL | MyBiosource | 5x20mL | EUR 220 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-1 | Glycomatrix | 20x1 mL | EUR 58.57 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-2 | Glycomatrix | 20 mL | EUR 53.99 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-3 | Glycomatrix | 50 mL | EUR 77.39 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-4 | Glycomatrix | 100 mL | EUR 116.22 |
Gentamicin Sulfate Solution, 10mg/mL, Sterile |
|||
| 40120796-5 | Glycomatrix | 100 mL | EUR 73.7 |
Gentamicin Sulfate Solution, 100mg/mL, Sterile |
|||
| 40120797-1 | Glycomatrix | 20 mL | EUR 59.15 |
Gentamicin Sulfate Solution, 100mg/mL, Sterile |
|||
| 40120797-2 | Glycomatrix | 100 mL | EUR 148.6 |
Gentamicin Sulfate Solution, 30mg/mL, Sterile |
|||
| 40120798-1 | Glycomatrix | 20 mL | EUR 37.61 |
Gentamicin Sulfate Solution, 30mg/mL, Sterile |
|||
| 40120798-2 | Glycomatrix | 100 mL | EUR 75.2 |
Gentamicin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40710024-1 | Glycomatrix | 20 mL | EUR 44.92 |
Gentamicin Sulfate Solution, 50mg/mL, Sterile |
|||
| 40710024-2 | Glycomatrix | 100 mL | EUR 112.16 |
Gentamicin Sulfate Solution (50 mg/mL in Water) |
|||
| G046-20ML | TOKU-E | 20 mL | EUR 69.12 |
|
Description: C21H43N5O7 |
|||
Gentamicin Sulfate Salt (C Complex) (Alcomicin, Bristagen, Cidomycin, Duragentam, Garamycin, Garasol,) |
|||
| MBS6116877-25g | MyBiosource | 2.5(g | EUR 485 |
Gentamicin Sulfate Salt (C Complex) (Alcomicin, Bristagen, Cidomycin, Duragentam, Garamycin, Garasol,) |
|||
| MBS6116877-5x25g | MyBiosource | 5x2.5g | EUR 2025 |
Gentamicin sulphate |
|||
| PCT1118-10G | EWC Diagnostics | 1 unit | EUR 85.92 |
|
Description: Gentamicin sulphate |
|||
